Wells Fargo & Company Inmune Bio, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 6,377 shares of INMB stock, worth $54,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,377

Previous 4,222 51.04%

Holding current value

$54,778

Previous $22,000 31.82%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$4.4 - $6.43 $9,482 - $13,856	2,155 Added 51.04%	6,377 $29,000
Q3 2024 Nov 13, 2024	BUY	$4.86 - $9.86 $1,258 - $2,553	259 Added 6.54%	4,222 $22,000
Q2 2024 Aug 13, 2024	BUY	$7.15 - $11.84 $27,284 - $45,181	3,816 Added 2595.92%	3,963 $34,000
Q1 2024 May 10, 2024	BUY	$10.53 - $14.01 $21 - $28	2 Added 1.38%	147 $1,000
Q4 2023 Feb 09, 2024	SELL	$6.6 - $11.52 $14,645 - $25,562	-2,219 Reduced 93.87%	145 $1,000
Q3 2023 Nov 13, 2023	SELL	$6.61 - $10.9 $5,717 - $9,428	-865 Reduced 26.79%	2,364 $16,000
Q2 2023 Aug 15, 2023	SELL	$6.5 - $10.09 $988 - $1,533	-152 Reduced 4.5%	3,229 $29,000
Q1 2023 May 12, 2023	SELL	$6.01 - $10.18 $25,374 - $42,979	-4,222 Reduced 55.53%	3,381 $21,000
Q4 2022 Feb 13, 2023	SELL	$6.13 - $7.96 $31,109 - $40,397	-5,075 Reduced 40.03%	7,603 $48,000
Q3 2022 Nov 14, 2022	SELL	$6.04 - $10.44 $5,731 - $9,907	-949 Reduced 6.96%	12,678 $78,000
Q2 2022 Aug 12, 2022	SELL	$5.48 - $8.97 $3,227 - $5,283	-589 Reduced 4.14%	13,627 $121,000
Q1 2022 May 16, 2022	BUY	$6.42 - $11.39 $17,378 - $30,832	2,707 Added 23.52%	14,216 $120,000
Q4 2021 Feb 14, 2022	BUY	$9.97 - $20.38 $88,553 - $181,015	8,882 Added 338.1%	11,509 $118,000
Q3 2021 Nov 15, 2021	BUY	$14.13 - $27.85 $36,384 - $71,713	2,575 Added 4951.92%	2,627 $51,000
Q1 2021 May 13, 2021	BUY	$11.61 - $26.85 $139 - $322	12 Added 30.0%	52 $1,000
Q3 2020 Nov 05, 2020	BUY	$4.92 - $15.75 $83 - $267	17 Added 73.91%	40 $0
Q2 2020 Aug 13, 2020	BUY	$3.1 - $6.09 $3 - $6	1 Added 4.55%	23 $0
Q1 2020 May 14, 2020	BUY	$2.21 - $6.15 $48 - $135	22 New	22 $0

Others Institutions Holding INMB

# of Institutions

Shares Held

7.04M

Call Options Held

202K

Put Options Held

42.9K

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $154M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Inmune Bio, Inc. Transaction History